Channing Capital Management, LLC Laboratory Corp Of America Holdings Transaction History

Channing Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$197.69 - $227.29 $6.67 Million - $7.66 Million	-33,723 Reduced 42.98%	44,731 $10.2 Million
Q3 2023 Nov 13, 2023	BUY	$201.05 - $221.7 $2.91 Million - $3.2 Million	14,451 Added 22.58%	78,454 $15.8 Million
Q2 2023 Aug 11, 2023	SELL	$211.93 - $241.33 $2.04 Million - $2.33 Million	-9,644 Reduced 13.09%	64,003 $15.4 Million
Q1 2023 May 09, 2023	SELL	$213.32 - $257.83 $4.88 Million - $5.9 Million	-22,870 Reduced 23.7%	73,647 $16.9 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $14.4 Million - $17.6 Million	70,662 Added 273.3%	96,517 $22.7 Million
Q3 2022 Nov 08, 2022	BUY	$204.81 - $262.19 $5.3 Million - $6.78 Million	25,855 New	25,855 $5.3 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Channing Capital Management, LLC with notifications on news.